VERTEX PHARMACEUTICALS (EUROPE) LIMITED NUF

915140009Norskregistrert utenlandsk foretak
Roles
1
Company details
Business address
2 Kingdom Street, 9 th Floor Paddington Central, LONDON W2 6BD
Sector
Private aksjeselskaper mv.
Registered
30.03.2015
Board and management

Styre og ledelse

Daglig leder

Revisor

BDO AS

Is revisor for 23 817 companies

Revisor

OTHER

VERTEX PHARMACEUTICALS (EUROPE) LIMITED

Is oppl om foretaket i hjemlandet for 1 companies

Oppl om foretaket i hjemlandet

Relationship graph

Explore in 3D
Loading graph...
Click a node to navigate. Drag to move. Company PersonStyreDaglig lederRevisorRegnskapInnehaverOpen in 3D →
Financials2024
Revenue
11.0 mill
Operating result
765k
Net result
643k
Assets
6.2 mill
Equity
2.9 mill
Debt
3.2 mill
Financial health check
Equity ratio
Very good
Current ratio
Good
Profitability
Good
Income statement and balance sheet
2024
Income statement
Revenue11.0 mill
Operating costs10.2 mill
= Operating result765k
Net finance45k
= Net result643k
Balance sheet
Fixed assets145k
Current assets6.0 mill
= Total assets6.2 mill
Equity2.9 mill
Long-term debt0
Short-term debt3.2 mill
= Total debt3.2 mill

Source: Brønnøysund Register Centre

Key Ratios
2024Industry (median)
Operating margin
7.0%4.0%
Net margin
5.9%
Return on assets
13.1%7.7%
Return on equity
21.9%
Equity ratio
47.5%36.7%
Current ratio
1.861.56
Debt-to-equity
1.101.25

Based on 474 companies

Source: Brønnøysund Register Centre. Ratios are calculated using universal formulas.

Powered by Webagent — digital solutions for Norwegian businesses

Powered by Webagent